Neonc Technologies (NTHI) News Today $7.22 -0.11 (-1.50%) As of 05/23/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock NTHI Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) President Acquires $14,780.00 in StockMay 24 at 8:42 AM | insidertrades.comNeonc technologies CFO Garnett Keithly acquires $976 in sharesMay 23 at 8:37 PM | investing.comInsider Buying: Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) President Buys 1,400 Shares of StockMay 20, 2025 | insidertrades.comNeOnc Technologies announces global patent portfolio totals 176April 16, 2025 | markets.businessinsider.comNeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical MarketsApril 15, 2025 | markets.businessinsider.comNeOnc Technologies expects full enrollment in Phase 2a trial of NEO100-01April 15, 2025 | markets.businessinsider.comNeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical MarketsApril 15, 2025 | globenewswire.comNeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in SeptemberApril 14, 2025 | markets.businessinsider.comNeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in SeptemberApril 14, 2025 | globenewswire.comNeOnc Technologies appoints Heshmatpour as PresidentApril 10, 2025 | markets.businessinsider.comNeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New PresidentApril 10, 2025 | finance.yahoo.comNeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New PresidentApril 10, 2025 | globenewswire.comNeOnc Technologies announces NEO212 trial nears full enrollmentApril 8, 2025 | markets.businessinsider.comNeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer TherapyApril 8, 2025 | markets.businessinsider.comNeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer TherapyApril 8, 2025 | globenewswire.comNeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer TherapyApril 8, 2025 | globenewswire.comNeonc Technologies Holdings Inc trading resumesApril 5, 2025 | markets.businessinsider.comNeonc Technologies Holdings Inc trading halted, volatility trading pauseApril 5, 2025 | markets.businessinsider.comNeonc Technologies appoints new accounting firmApril 3, 2025 | investing.comNeOnc Technologies receives RPDD for NEO100April 2, 2025 | markets.businessinsider.comNeOnc Technologies Holdings IncMarch 31, 2025 | morningstar.comNeOnc Falls Despite FDA NodMarch 31, 2025 | baystreet.caNeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade GliomasMarch 31, 2025 | globenewswire.comLIVE: NeOnc Technologies Holdings, Inc. Rings the Opening BellMarch 28, 2025 | nasdaq.comNeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer TreatmentsMarch 27, 2025 | globenewswire.comNeOnc Technologies Holdings, Inc. Appoints Dr. Steven L. Giannotta to Board of DirectorsMarch 27, 2025 | nasdaq.comNeOnc Technologies Holdings, Inc. Appoints Dr. Victoria Medvec to Board of DirectorsMarch 26, 2025 | markets.businessinsider.comNeOnc Technologies Holdings, Inc. Appoints Bader Almonawer to Board of DirectorsMarch 25, 2025 | finance.yahoo.comNEONC Technologies Holdings, Inc. Appoints Dr. Alan Chiang to its Board of DirectorsMarch 25, 2025 | markets.businessinsider.comNeOnc Technologies Holdings Announces Effectiveness of Registration Statement and Anticipated Listing Date of Common Stock on Nasdaq Global MarketMarch 25, 2025 | markets.businessinsider.comNeOnc Technologies Appointments the Honorable Jimmy Delshad to its Board of DirectorsMarch 25, 2025 | globenewswire.comNEONC Technologies Holdings, Inc. Appoints Renowned Neurosurgeon Dr. Steven L. Giannotta to its Board of DirectorsMarch 25, 2025 | globenewswire.comBuilding biotech excellence: the growth strategy behind NeOnc Technologies’ visionMarch 13, 2025 | venturebeat.comNeOnc files for direct listing in wake of pulled IPOJanuary 3, 2025 | msn.comNeOnc Technologies Receives Pharma Tech Outlook’s Top Drug Delivery Platform Award for 2024October 8, 2024 | markets.businessinsider.comNeOnc Technologies Receives Pharma Tech Outlook's Top Drug Delivery Platform Award for 2024October 7, 2024 | globenewswire.comNeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted with Meningioma, Marking Second Concurrent Phase 2 Study of Leading CNS Cancer Drug CandidateAugust 5, 2024 | globenewswire.comNeOnc Technologies Receives FDA Approval to Expand NEO100-01™ Phase 2a Clinical Trial to Include Patients with Recurrent Grade III Astrocytoma Brain Tumors Exhibiting IDH1 MutationJuly 16, 2024 | globenewswire.comNeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced Method of Delivering Novel Therapeutics to the Brain Under FDA Fast-Track StatusJune 26, 2024 | globenewswire.comNeOnc Technologies Wins California Investment Forum's Breakthrough Medical Technology Achievement AwardMay 15, 2024 | globenewswire.comNeOnc Technologies Invited to Present at California Investment Forum in Anaheim on May 10May 9, 2024 | globenewswire.com Get Neonc Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for NTHI and its competitors with MarketBeat's FREE daily newsletter. Email Address NTHI Media Mentions By Week NTHI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTHI News Sentiment▼1.100.67▲Average Manufacturing News Sentiment NTHI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTHI Articles This Week▼181▲NTHI Articles Average Week Get Neonc Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for NTHI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BCTXW News ENGNW News FBIOP News GOVXW News LEXXW News RVPHW News RCKTW News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NTHI) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neonc Technologies Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neonc Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NTHI Stock Free NTHI Stock Alerts